
Taking a Closer Look At Aurinia Pharmaceuticals Inc (AUPH) Following Its Recent Trade
In a filing, Aurinia Pharmaceuticals Inc revealed its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
In a filing, Aurinia Pharmaceuticals Inc revealed its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
In a filing, Aurinia Pharmaceuticals Inc revealed its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
In a filing, Aurinia Pharmaceuticals Inc revealed its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
In a filing, Aurinia Pharmaceuticals Inc revealed its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on